Quick Look At Sell-Side Ratings on GAIN Capital Holdings, Inc. (NYSE:GCAP) & Antares Pharma, Inc. (NASDAQ:ATRS)

Brokerage firms currently have a positive stance on shares of GAIN Capital Holdings, Inc. (NYSE:GCAP). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.50. Those same analysts are projecting that the stock will reach $7.67 on a short term basis.

GAIN Capital Holdings, Inc. (NYSE:GCAP) shares typically trade an average volume of 336.37 and institutions hold 78.70% of the total shares.  

MOVING AVERAGES

We see here that the stock is 8.30% away from the 20-Day Simple Moving Average.  Their 50-Day Simple Moving Average is a difference of 15.95% from current levels.  Further back, their 200-Day Simple Moving Average is 15.76% difference from today’s price.  Currently, the stock is -11.51% from its 50-Day High and 31.13% from the 50-day low. 

GAIN Capital Holdings, Inc. (NYSE:GCAP)‘s stock has performed at 20.36%.  Breaking that down further, it has performed -4.92% for the week, 11.86% for the month, 24.33% over the last quarter, 36.08% for the past half-year and 19.64% for this last year. 

Equity Research firms currently have a positive stance on shares of Antares Pharma, Inc. (NASDAQ:ATRS). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 1.40. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $3.73 on a short term basis.

Antares Pharma, Inc. (NASDAQ:ATRS)’s shares may have a significant upside to the consensus target of 3.73, but how has it been performing relative to the market?  The stock’s price is 1.94 and their relative strength index (RSI) stands at 42.92.  RSI is a technical oscillator that shows price strength by comparing upward and downward movements.  It indicates oversold and overbought price levels for a stock.  

Antares Pharma, Inc. (NASDAQ:ATRS) shares are moving 4.86% trading at $1.94 today.

Leave a Comment